IP Library Granted Patent US 12,259,394
Granted Patent B2
US 12,259,394 · App. 18/627,091 · Granted Mar 25, 2025

Protein sequencing via coupling of polymerizable molecules

Inventors: Asmamaw Wassie (Leander, TX); Daniel Masao Estandian (Antioch, CA); Andrew John Price (San Mateo, CA); Boyang Hua (Oakland, CA); Joshua Young Cynming Yang (Richardson, TX); David Dodd (San Francisco, CA); Gerardo Fabian Delgado (Oakland, CA); Elaine Jean Su (Martinez, CA)
Assignee: Glyphic Biotechnologies, Inc.
G01N33/6818C12Q1/68
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,259,394
App. No.
18/627,091
Granted
Mar 25, 2025
Kind
B2
Abstract

The present disclosure provides methods and systems for sequencing proteins. One or more methods disclosed herein may use linkers having an amino acid-reactive group and an additional reactive moiety that may be used to couple a polymerizable molecule. The linker may couple to a polymerizable molecule and an amino acid of a peptide and a capture moiety via the polymerizable molecule, followed by cleavage of the amino acid from the peptide. Further processing and analysis may be conducted using, for example, nanopores or nanogaps.

Claims (39)

1. A method of sequencing a peptide at single amino acid resolution, comprising:

(a) providing said peptide and a linker, wherein said linker comprises a polymerizable molecule, and wherein said linker is capable of coupling to an amino acid of said peptide;

(b) coupling said linker to said amino acid of said peptide;

(c) coupling said linker to a capture moiety;

(d) cleaving said amino acid from said peptide to yield an amino acid-linker-capture moiety (AALC) complex;

(e) providing an additional linker, wherein said additional linker is capable of coupling to an additional amino acid of said peptide;

(f) coupling said additional linker to said additional amino acid, thereby generating an additional amino acid-linker complex; and

(g) coupling said additional amino acid-linker complex to said AALC complex, thereby generating a stacked AALC complex;

(h) contacting said stacked AALC complex with a plurality of binding agents, wherein individual binding agents of said plurality of binding agents have different specificity to different amino acid types;

(i) translocating said stacked AALC complex contacted with said plurality of binding agents through a nanopore or a nanogap; and

(j) identifying an amino acid type of said amino acid or said additional amino acid.

2. The method of claim 1 , wherein said capture moiety is affixed to a substrate.

3. The method of claim 2 , wherein said substrate is substantially planar.

4. The method of claim 2 , wherein said substrate is a bead.

5. The method of claim 1 , wherein said capture moiety comprises a nucleic acid molecule.

6. The method of claim 5 , wherein said nucleic acid molecule comprises a DNA molecule, an RNA molecule, an XNA molecule, or modified variant thereof.

7. The method of claim 6 , wherein said DNA molecule is single-stranded.

8. The method of claim 1 , wherein said capture moiety comprises a first nucleic acid molecule, wherein said linker comprises a second nucleic acid molecule, and wherein said coupling of (c) comprises coupling said first nucleic acid molecule to said second nucleic acid molecule.

9. The method of claim 8 , wherein said coupling of (c) is performed using a ligase.

10. The method of claim 8 , wherein at least a portion of said first nucleic acid molecule is complementary to at least a portion of said second nucleic acid molecule.

11. The method of claim 10 , wherein said coupling is performed by hybridizing said at least said portion of said first nucleic acid molecule to said at least said portion of said second nucleic acid molecule.

12. The method of claim 8 , wherein said coupling is performed using a splint oligonucleotide, wherein said splint oligonucleotide comprises a first sequence complementary to at least a portion of said first nucleic acid molecule and a second sequence complementary to at least a portion of said second nucleic acid molecule.

13. The method of claim 1 , wherein said capture moiety comprises a nucleic acid barcode molecule.

14. The method of claim 13 , wherein said nucleic acid barcode molecule identifies said peptide.

15. The method of claim 1 , wherein said capture moiety is coupled to said peptide.

16. The method of claim 1 , wherein said amino acid or said additional amino acid is an N-terminal amino acid or a C-terminal amino acid.

17. The method of claim 1 , wherein (b) occurs before (c).

18. The method of claim 1 , wherein (c) occurs before (b).

19. The method of claim 1 , further comprising, repeating (e)-(g) to generate said stacked AALC complex.

20. The method of claim 1 , wherein said identifying further comprises measuring a signal as said stacked AALC complex contacted with said plurality of binding agents translocates through said nanopore or said nanogap.

21. The method of claim 1 , wherein said translocating of (i) occurs at a temperature below ambient temperature.

22. The method of claim 1 , wherein said linker comprises a nucleic acid barcode molecule that comprises temporal information.

23. The method of claim 1 , wherein said capture moiety comprises a cleavable moiety.

24. The method of claim 1 , wherein said nanopore or said nanogap is a solid-state nanopore.

25. The method of claim 1 , wherein said plurality of binding agents comprises an antibody, antibody fragment, nanobody, or aptamer.

26. The method of claim 1 , wherein said cleaving of (d) is performed using treatment with acid.

27. The method of claim 26 , wherein said acid is a Lewis acid.

28. The method of claim 1 , wherein said amino acid comprises a post-translational modification or a non-standard amino acid, and wherein (j) comprises identifying said post-translational modification or said non-standard amino acid.

29. The method of claim 1 , wherein (a)-(g) are performed in absence of a substrate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2024
From: ESTANDIAN, DANIEL MASAO; PRICE, ANDREW JOHN; HUA, BOYANG; YANG, JOSHUA YOUNG CYNMING; DODD, DAVID; DELGADO, GERARDO FABIAN; SU, ELAINE JEAN
To: GLYPHIC BIOTECHNOLOGIES, INC.
Reel/Frame 069509/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2024
From: WASSIE, ASMAMAW
To: GLYPHIC BIOTECHNOLOGIES, INC.
Reel/Frame 069509/0122 →
Continuity (3)
Continuation PCTUS2023071456 · Aug 1, 2023
Provisional Application 63394475 · Aug 2, 2022
Related Publication 20240337661A1 · Oct 10, 2024
References Cited (82)
US 4665037A · Stolowitz · 1987 [cited by applicant]
US 5254475A · Bailey · 1993 [cited by applicant]
US 8105846B2 · Bayley et al. · 2012 [cited by applicant]
US 8426807B2 · Stein · 2013 [cited by applicant]
US 8557529B2 · Polonsky et al. · 2013 [cited by applicant]
US 8829432B2 · Stein · 2014 [cited by applicant]
US 9494554B2 · Davis et al. · 2016 [cited by applicant]
US 9558319B1 · Lathrop · 2017 [cited by applicant]
US 9566335B1 · Emili et al. · 2017 [cited by applicant]
US 10006879B2 · Ervin et al. · 2018 [cited by applicant]
US 11214830B2 · Turner et al. · 2022 [cited by applicant]
US 11499190B2 · Davis et al. · 2022 [cited by applicant]
US 11499979B2 · Estandian et al. · 2022 [cited by applicant]
US 11673136B2 · Qing et al. · 2023 [cited by applicant]
US 20140273004A1 · Havranek et al. · 2014 [cited by applicant]
US 20150087526A1 · Hesselberth · 2015 [cited by examiner]
US 20170002053A1 · Julius et al. · 2017 [cited by applicant]
US 20180284125A1 · Gordon et al. · 2018 [cited by applicant]
US 20180299460A1 · Emili · 2018 [cited by applicant]
US 20180372752A1 · Emili et al. · 2018 [cited by applicant]
US 20190145982A1 · Chee · 2019 [cited by examiner]
US 20200217853A1 · Estandian · 2020 [cited by examiner]
US 20200219590A1 · Reed · 2020 [cited by examiner]
US 20200284783A1 · Schmidt et al. · 2020 [cited by applicant]
US 20200348307A1 · Beierle · 2020 [cited by examiner]
US 20200348308A1 · Chee et al. · 2020 [cited by applicant]
US 20210033591A1 · Ambroso et al. · 2021 [cited by applicant]
US 20210132076A1 · Marcotte et al. · 2021 [cited by applicant]
US 20210355483A1 · Chee et al. · 2021 [cited by applicant]
US 20210396762A1 · Chee et al. · 2021 [cited by applicant]
US 20220227889A1 · Gunderson · 2022 [cited by examiner]
US 20230016396A1 · Gunderson · 2023 [cited by examiner]
US 20230024319A1 · Heron et al. · 2023 [cited by applicant]
US 20230056532A1 · Gunderson et al. · 2023 [cited by applicant]
US 20230076975A1 · Anslyn et al. · 2023 [cited by applicant]
US 20230104998A1 · Estandian · 2023 [cited by examiner]
US 20230213527A1 · Reed · 2023 [cited by examiner]
EP 2272981B1 · 2013 [cited by applicant]
EP 2342359B1 · 2015 [cited by applicant]
EP 2851433B1 · 2017 [cited by applicant]
EP 3526349B1 · 2021 [cited by applicant]
EP 3891300A1 · 2021 [cited by applicant]
EP 4070092B1 · 2023 [cited by applicant]
KR 102034304B1 · 2019 [cited by applicant]
WO WO2013188841A1 · 2013 [cited by applicant]
WO WO2017192633A1 · 2017 [cited by applicant]
WO WO2018017914A1 · 2018 [cited by applicant]
WO WO2019089846A1 · 2019 [cited by applicant]
WO WO2019195633A1 · 2019 [cited by applicant]
WO WO2020146325A1 · 2020 [cited by applicant]
WO WO2020223000A1 · 2020 [cited by applicant]
WO WO2021051011A1 · 2021 [cited by applicant]
WO WO2022150659A1 · 2022 [cited by applicant]
WO WO2022243692A1 · 2022 [cited by applicant]
WO WO2023196642A1 · 2023 [cited by applicant]
WO WO2024030919A1 · 2024 [cited by applicant]
Howorka, et al., Reading amino acids in a nanopore, Nature Biotechnology, 38(2):159-160, (2020). [cited by applicant]
Nookaew, et al., Detection and Discrimination of DNA Adducts Differing in Size, Regiochemistry, and Functional Group by Nanopore Sequencing. Chemical Research in Toxicology, 33(12):2944-2952, (2020). [cited by applicant]
Ouldali, et al., Electrical recognition of the twenty proteinogenic amino acids using an aerolysin nanopore, Nature Biotechnology, 38(2):176-181, (2020). [cited by applicant]
Wei, et al., Enabling nanopore technology for sensing individual amino acids by a derivatization strategy. Journal of Material Chemistry B., 8(31):6792-6797, (2020). [cited by applicant]
Alfaro, J.A. et al., The emerging landscape of single-molecule protein sequencing technologies, Nature Methods, vol. 18, 6 (2021):604-617. [cited by applicant]
Ang, Y. et al., Rational design of hybridization chain reaction monomers for robust signal amplification, Chemical Communications, vol. 22, (2016). [cited by applicant]
Bird, R.E. et al., Single-Chain Antigen-binding Proteins, Science, vol. 242, 4877 (1988):423-426. [cited by applicant]
Bloom, S. et al., Decarboxylative alkylation for site-selective bioconjugation of native proteins via oxidation potentials, Nature Chemistry, vol. 10, 2, (2018):205-211. [cited by applicant]
Cherf, G.M. et al., Automated forward and reverse ratcheting of DNA in a nanopore at 5-Å precision, Nat. Biotechnol., vol. 30, 4 (2012):344-348. [cited by applicant]
Estandian, D.M. et al., Enabling tools for the de-novo single molecule protein sequencing, (2021):1-85. [cited by applicant]
Extended European Search Report issued Sep. 13, 2022, in European Patent Application No. 20739125.1 (8 pages). [cited by applicant]
Grammel, M. et al., Chemical reporters for biological discovery, Nature Chemical Biology, vol. 9, 8 (2013):475-484. [cited by applicant]
Hong, J.M. et al., ProtSeq: Toward high-throughput, single-molecule protein sequencing via amino acid conversion into DNA barcodes, ScienceDirect, vol. 25, 1 (2021):103586. [cited by applicant]
Hunkapiller, T. et al., The growing immunoglobulin gene superfamily, Nature, vol. 323, 6083 (1986):15-16. [cited by applicant]
Huston, J.S. et al., Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in [cited by applicant]
Knight, Z.A. et al., Phosphospecific proteolysis for mapping sites of protein phosphorylation, Nat. Biotechnology, vol. 21, 9 (2003):1047-1054. [cited by applicant]
Krishna, O.D. et al., Protein- and Peptide-Modified Synthetic Polymeric Biomaterials, Biopolymers, vol. 94, 1 (2010):32-48. [cited by applicant]
Lanzavecchia, A. et al., The use of hybrid hybridomas to target human cytotoxic T lymphocytes, Eur. J. Immunol., vol. 17, (1987):105-111. [cited by applicant]
Li, Z. et al., Design and Synthesis of Minimalist Terminal Alkyne-Containing Diazirine Photo-Crosslinkers and Their incorporation into Kinase Inhibitors for Cell-and Tissue-Based Proteome Profiling, Angew. Chem., vol. 1… [cited by applicant]
Liu, R. et al., Development and Applications of Topologically Segregated Bilayer Beads in One-bead One-compound Combinatorial Libraries, QSAR & Combinatorial Science, vol. 24, 10 (2005):1127-1140. [cited by applicant]
Margolis, S.A. et al., The hydrolysis of proteins by microwave energy, Journal of Automatic Chemistry, vol. 13, 3 (1991):93-95. [cited by applicant]
Wilbanks, B. et al., Phenoxy radical reactivity of nucleic acids: practical implications for biotinylation, Chembiochem, vol. 22, 8 (2021):1400-1404. [cited by applicant]
Xie, T. et al., Selective C-Terminal Conjugation of Protease-Derived Native Peptides for Proteomic Measurements, Langmuir, vol. 38, 30 (2022):9119-9128. [cited by applicant]
Xu, G. et al., Chemoenzymatic Labeling of Protein C-Termini for Positive Selection of C-Terminal Peptides, ACS Chem Biol., vol. 6, 10 (2011): 1015-1020. [cited by applicant]
Zhang, L. et al., Photoredox-Catalyzed Decarboxylative C-Terminal Differentiation for Bulk-and Single-Molecule Proteomics, ACS Chem. Biol., vol. 16, 11 (2021):2595-2603. [cited by applicant]
Zhu, T. et al., Enzymatic clickable functionalization of peptides via computationally engineered peptide amidase, Chinese Chemical Letters, vol. 29, 7 (2018):1116-1118. [cited by applicant]
Cited By (2)
US 12,399,180 US 12,399,181